Key Insights

Highlights

Success Rate

93% trial completion (above average)

Published Results

53 trials with published results (52%)

Research Maturity

71 completed trials (70% of total)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 5/100

Termination Rate

5.0%

5 terminated out of 101 trials

Success Rate

93.4%

+6.9% vs benchmark

Late-Stage Pipeline

35%

35 trials in Phase 3/4

Results Transparency

75%

53 of 71 completed with results

Key Signals

53 with results93% success

Data Visualizations

Phase Distribution

81Total
Not Applicable (10)
P 1 (9)
P 2 (27)
P 3 (32)
P 4 (3)

Trial Status

Completed71
Unknown15
Recruiting6
Terminated5
Not Yet Recruiting2
Withdrawn1

Trial Success Rate

93.4%

Benchmark: 86.5%

Based on 71 completed trials

Clinical Trials (101)

Showing 20 of 20 trials
NCT07037277Phase 3Recruiting

C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV

NCT05363865Not ApplicableCompleted

Digital Community to Improve Health in Rural Areas

NCT06870019Not ApplicableRecruitingPrimary

Hepatitis C Tracker Study

NCT05975216CompletedPrimary

Relinking Diagnosed But Untreated HCV Patients Back Into Care.

NCT07098481Phase 4Not Yet RecruitingPrimary

Access to Hepatitis C Treatment in Cameroon: Comparison of a Simplified Test and Treat Strategy to a Standard Strategy

NCT06431945RecruitingPrimary

Early Detection of HCV in Injection Drug Users

NCT06718530RecruitingPrimary

Characterization of Immune Genotypes and Antibody Profiles to Foster the discoVERY of diagnosticbioMARKERS of Liver Cancer Development

NCT05071261Not Yet RecruitingPrimary

Screening, Treatment, and Eradication of Hep C

NCT04156945Not ApplicableActive Not RecruitingPrimary

Interventions to Curb Hepatitis C Reinfections Among Men Who Have Sex With Men

NCT06463912RecruitingPrimary

Screening for Hepatitis c in People Who Inject Drugs in Armenia-Colombia

NCT06155006RecruitingPrimary

Adult Screening for Hepatitis c and Linkage to Treatment in Hospitals in Colombia

NCT02292706TerminatedPrimary

A Registry for Participants With Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment With a Sofosbuvir-Based Regimen Without Interferon for Chronic Hepatitis C Infection

NCT05906459UnknownPrimary

Simplification and Test and Treat Strategies Towards Hepatitis C Eliminationplatform" in China(STAT)

NCT04035980Not ApplicableUnknownPrimary

Telemedicine for Linkage to Care People Who Injected Drugs With Hepatitis C

NCT05460130Not ApplicableUnknownPrimary

Implementing HCV Treatment for High-risk Populations in Austin, Texas

NCT02510300TerminatedPrimary

A Registry for Adolescent and Pediatric Participants Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trials

NCT04980157CompletedPrimary

CARES-HCV: Promoting Screening Uptake Among Diverse Baby Boomers

NCT04852614UnknownPrimary

Pharmacokinetics of Sofosbuvir/Daclatasvir in HCV-infected Lactating Women

NCT05452187Completed

Evaluation of the Safety and Effectiveness of Direct-acting Antiviral Drugs in the Treatment of Hepatitis C in Patients With Inflammatory Bowel Disease: National Multicenter Study

NCT04309734Phase 1Withdrawn

Study of AT-777 in Healthy Subjects and AT-777 in Combination With AT-527 in HCV-Infected Subjects

Scroll to load more

Research Network

Activity Timeline